2025
SJR Q2
JCR Q2 · 3,1
31 matched articles
SCIE
Journal detail
Clinical Drug Investigation
- Country
- Switzerland · Western Europe
- Type
- journal
- ISSN
-
1173256311791918
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,823
- Quartile Q2
- H-Index 75
- Cites/doc 2,81
- Docs (3y) 282
- Cites (3y) 761
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,1
- 5Y JIF 2,7
- JCI 0,68
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Medicine (miscellaneous) Q2
- Pharmacology (medical) Q2
Areas
- Medicine
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,823 | 3,1 | 2,7 | 0,68 | Q2 | 75 |
| 2024 | Q2 | Q2 | 0,771 | 2,7 | 2,5 | 0,75 | Q2 | 70 |
| 2023 | Q2 | Q2 | 0,68 | 2,9 | 2,5 | 0,8 | Q2 | 70 |
| 2022 | Q2 | Q3 | 0,68 | 3,2 | 2,5 | 0,77 | Q2 | 70 |
| 2021 | Q2 | Q3 | 0,718 | 3,6 | 3 | 0,77 | Q2 | 70 |
| 2020 | Q2 | Q3 | 0,739 | 2,9 | 2,5 | 0,72 | Q2 | 70 |
| 2019 | Q2 | Q3 | 0,725 | 2,3 | 2 | 0,76 | Q2 | 70 |
| 2018 | — | Q3 | — | 2,2 | 1,9 | 0,74 | Q2 | — |
| 2017 | Q2 | Q3 | 0,719 | 1,9 | 1,8 | 0,76 | Q2 | 70 |
| 2016 | Q2 | Q3 | 0,592 | 1,9 | 1,7 | — | — | 70 |
| 2015 | Q2 | Q3 | 0,664 | 1,8 | 1,7 | — | — | 70 |
| 2014 | Q2 | Q3 | 0,621 | 1,6 | 1,6 | — | — | 70 |
| 2013 | Q2 | Q3 | 0,646 | 1,7 | 1,5 | — | — | 70 |
| 2012 | Q2 | Q3 | 0,647 | 1,9 | 1,6 | — | — | 70 |
| 2011 | Q2 | Q3 | 0,563 | 1,8 | 1,4 | — | — | 70 |
| 2010 | Q2 | Q3 | 0,579 | 1,6 | 1,3 | — | — | 70 |
| 2009 | — | Q3 | — | 1,4 | 1,2 | — | — | — |
| 2008 | — | Q3 | — | 1,3 | 1 | — | — | — |
| 2007 | — | Q4 | — | 0,6 | 0,6 | — | — | — |
| 2006 | — | Q4 | — | 0,6 | — | — | — | — |
| 2005 | — | Q4 | — | 0,7 | — | — | — | — |
| 2004 | — | Q4 | — | 0,8 | — | — | — | — |
| 2003 | — | Q4 | — | 0,7 | — | — | — | — |
| 2002 | — | Q3 | — | 0,9 | — | — | — | — |
| 2001 | — | Q3 | — | 0,8 | — | — | — | — |
| 2000 | — | Q3 | — | 0,9 | — | — | — | — |
| 1999 | — | Q4 | — | 0,7 | — | — | — | — |
| 1998 | — | Q3 | — | 0,7 | — | — | — | — |
| 1997 | — | Q3 | — | 0,9 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 163/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 164/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 147/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 146/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 140/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 173/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 175/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 169/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 181/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 176/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 165/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 179/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 167/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 158/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 152/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 169/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 168/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 164/219 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 191/205 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 185/199 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 169/193 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 154/187 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 150/185 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 135/188 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 133/186 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 126/181 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 134/175 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 121/178 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 99/157 |